Cargando…

Interactions between human immunodeficiency virus (HIV)-1 Vpr expression and innate immunity influence neurovirulence

BACKGROUND: Viral diversity and abundance are defining properties of human immunodeficiency virus (HIV)-1's biology and pathogenicity. Despite the increasing availability of antiretroviral therapy, HIV-associated dementia (HAD) continues to be a devastating consequence of HIV-1 infection of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Na, Hong, Acharjee, Shaona, Jones, Gareth, Vivithanaporn, Pornpun, Noorbakhsh, Farshid, McFarlane, Nicola, Maingat, Ferdinand, Ballanyi, Klaus, Pardo, Carlos A, Cohen, Éric A, Power, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123635/
https://www.ncbi.nlm.nih.gov/pubmed/21645334
http://dx.doi.org/10.1186/1742-4690-8-44
_version_ 1782207008633520128
author Na, Hong
Acharjee, Shaona
Jones, Gareth
Vivithanaporn, Pornpun
Noorbakhsh, Farshid
McFarlane, Nicola
Maingat, Ferdinand
Ballanyi, Klaus
Pardo, Carlos A
Cohen, Éric A
Power, Christopher
author_facet Na, Hong
Acharjee, Shaona
Jones, Gareth
Vivithanaporn, Pornpun
Noorbakhsh, Farshid
McFarlane, Nicola
Maingat, Ferdinand
Ballanyi, Klaus
Pardo, Carlos A
Cohen, Éric A
Power, Christopher
author_sort Na, Hong
collection PubMed
description BACKGROUND: Viral diversity and abundance are defining properties of human immunodeficiency virus (HIV)-1's biology and pathogenicity. Despite the increasing availability of antiretroviral therapy, HIV-associated dementia (HAD) continues to be a devastating consequence of HIV-1 infection of the brain although the underlying disease mechanisms remain uncertain. Herein, molecular diversity within the HIV-1 non-structural gene, Vpr, was examined in RNA sequences derived from brain and blood of HIV/AIDS patients with or without HIV-associated dementia (HAD) together with the ensuing pathobiological effects. RESULTS: Cloned brain- and blood-derived full length vpr alleles revealed that amino acid residue 77 within the brain-derived alleles distinguished HAD (77Q) from non-demented (ND) HIV/AIDS patients (77R) (p < 0.05) although vpr transcripts were more frequently detected in HAD brains (p < 0.05). Full length HIV-1 clones encoding the 77R-ND residue induced higher IFN-α, MX1 and BST-2 transcript levels in human glia relative to the 77Q-HAD encoding virus (p < 0.05) but both viruses exhibited similar levels of gene expression and replication. Myeloid cells transfected with 77Q-(pVpr77Q-HAD), 77R (pVpr77R-ND) or Vpr null (pVpr((-)))-containing vectors showed that the pVpr77R-ND vector induced higher levels of immune gene expression (p < 0.05) and increased neurotoxicity (p < 0.05). Vpr peptides (amino acids 70-96) containing the 77Q-HAD or 77R-ND motifs induced similar levels of cytosolic calcium activation when exposed to human neurons. Human glia exposed to the 77R-ND peptide activated higher transcript levels of IFN-α, MX1, PRKRA and BST-2 relative to 77Q-HAD peptide (p < 0.05). The Vpr 77R-ND peptide was also more neurotoxic in a concentration-dependent manner when exposed to human neurons (p < 0.05). Stereotaxic implantation of full length Vpr, 77Q-HAD or 77R-ND peptides into the basal ganglia of mice revealed that full length Vpr and the 77R-ND peptide caused greater neurobehavioral deficits and neuronal injury compared with 77Q-HAD peptide-implanted animals (p < 0.05). CONCLUSIONS: These observations underscored the potent neuropathogenic properties of Vpr but also indicated viral diversity modulates innate neuroimmunity and neurodegeneration.
format Online
Article
Text
id pubmed-3123635
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31236352011-06-26 Interactions between human immunodeficiency virus (HIV)-1 Vpr expression and innate immunity influence neurovirulence Na, Hong Acharjee, Shaona Jones, Gareth Vivithanaporn, Pornpun Noorbakhsh, Farshid McFarlane, Nicola Maingat, Ferdinand Ballanyi, Klaus Pardo, Carlos A Cohen, Éric A Power, Christopher Retrovirology Research BACKGROUND: Viral diversity and abundance are defining properties of human immunodeficiency virus (HIV)-1's biology and pathogenicity. Despite the increasing availability of antiretroviral therapy, HIV-associated dementia (HAD) continues to be a devastating consequence of HIV-1 infection of the brain although the underlying disease mechanisms remain uncertain. Herein, molecular diversity within the HIV-1 non-structural gene, Vpr, was examined in RNA sequences derived from brain and blood of HIV/AIDS patients with or without HIV-associated dementia (HAD) together with the ensuing pathobiological effects. RESULTS: Cloned brain- and blood-derived full length vpr alleles revealed that amino acid residue 77 within the brain-derived alleles distinguished HAD (77Q) from non-demented (ND) HIV/AIDS patients (77R) (p < 0.05) although vpr transcripts were more frequently detected in HAD brains (p < 0.05). Full length HIV-1 clones encoding the 77R-ND residue induced higher IFN-α, MX1 and BST-2 transcript levels in human glia relative to the 77Q-HAD encoding virus (p < 0.05) but both viruses exhibited similar levels of gene expression and replication. Myeloid cells transfected with 77Q-(pVpr77Q-HAD), 77R (pVpr77R-ND) or Vpr null (pVpr((-)))-containing vectors showed that the pVpr77R-ND vector induced higher levels of immune gene expression (p < 0.05) and increased neurotoxicity (p < 0.05). Vpr peptides (amino acids 70-96) containing the 77Q-HAD or 77R-ND motifs induced similar levels of cytosolic calcium activation when exposed to human neurons. Human glia exposed to the 77R-ND peptide activated higher transcript levels of IFN-α, MX1, PRKRA and BST-2 relative to 77Q-HAD peptide (p < 0.05). The Vpr 77R-ND peptide was also more neurotoxic in a concentration-dependent manner when exposed to human neurons (p < 0.05). Stereotaxic implantation of full length Vpr, 77Q-HAD or 77R-ND peptides into the basal ganglia of mice revealed that full length Vpr and the 77R-ND peptide caused greater neurobehavioral deficits and neuronal injury compared with 77Q-HAD peptide-implanted animals (p < 0.05). CONCLUSIONS: These observations underscored the potent neuropathogenic properties of Vpr but also indicated viral diversity modulates innate neuroimmunity and neurodegeneration. BioMed Central 2011-06-06 /pmc/articles/PMC3123635/ /pubmed/21645334 http://dx.doi.org/10.1186/1742-4690-8-44 Text en Copyright ©2011 Na et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Na, Hong
Acharjee, Shaona
Jones, Gareth
Vivithanaporn, Pornpun
Noorbakhsh, Farshid
McFarlane, Nicola
Maingat, Ferdinand
Ballanyi, Klaus
Pardo, Carlos A
Cohen, Éric A
Power, Christopher
Interactions between human immunodeficiency virus (HIV)-1 Vpr expression and innate immunity influence neurovirulence
title Interactions between human immunodeficiency virus (HIV)-1 Vpr expression and innate immunity influence neurovirulence
title_full Interactions between human immunodeficiency virus (HIV)-1 Vpr expression and innate immunity influence neurovirulence
title_fullStr Interactions between human immunodeficiency virus (HIV)-1 Vpr expression and innate immunity influence neurovirulence
title_full_unstemmed Interactions between human immunodeficiency virus (HIV)-1 Vpr expression and innate immunity influence neurovirulence
title_short Interactions between human immunodeficiency virus (HIV)-1 Vpr expression and innate immunity influence neurovirulence
title_sort interactions between human immunodeficiency virus (hiv)-1 vpr expression and innate immunity influence neurovirulence
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123635/
https://www.ncbi.nlm.nih.gov/pubmed/21645334
http://dx.doi.org/10.1186/1742-4690-8-44
work_keys_str_mv AT nahong interactionsbetweenhumanimmunodeficiencyvirushiv1vprexpressionandinnateimmunityinfluenceneurovirulence
AT acharjeeshaona interactionsbetweenhumanimmunodeficiencyvirushiv1vprexpressionandinnateimmunityinfluenceneurovirulence
AT jonesgareth interactionsbetweenhumanimmunodeficiencyvirushiv1vprexpressionandinnateimmunityinfluenceneurovirulence
AT vivithanapornpornpun interactionsbetweenhumanimmunodeficiencyvirushiv1vprexpressionandinnateimmunityinfluenceneurovirulence
AT noorbakhshfarshid interactionsbetweenhumanimmunodeficiencyvirushiv1vprexpressionandinnateimmunityinfluenceneurovirulence
AT mcfarlanenicola interactionsbetweenhumanimmunodeficiencyvirushiv1vprexpressionandinnateimmunityinfluenceneurovirulence
AT maingatferdinand interactionsbetweenhumanimmunodeficiencyvirushiv1vprexpressionandinnateimmunityinfluenceneurovirulence
AT ballanyiklaus interactionsbetweenhumanimmunodeficiencyvirushiv1vprexpressionandinnateimmunityinfluenceneurovirulence
AT pardocarlosa interactionsbetweenhumanimmunodeficiencyvirushiv1vprexpressionandinnateimmunityinfluenceneurovirulence
AT cohenerica interactionsbetweenhumanimmunodeficiencyvirushiv1vprexpressionandinnateimmunityinfluenceneurovirulence
AT powerchristopher interactionsbetweenhumanimmunodeficiencyvirushiv1vprexpressionandinnateimmunityinfluenceneurovirulence